| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | PerimeterX | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $119.16M | Series D | 2/23/2021 | $30.9M | $401.9M | $2.97 | Alliance Bernstein, Stereo Capital, JS Capital, Golden Arc Capital, Adams Street Partners, Canaan Partners, DTCP, Scale Venture Partners, Vertex Ventures | ||||
 | Pex | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $14.79M | Series C-2 | 2/18/2026 | $5M | $98.91M | $4.78 | Undisclosed Investors | ||||
 | Privateer | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $73.15M | Series A | 5/6/2024 | $47.76M | $154.93M | $0.43 | Aero X Ventures, Lux Capital, BOKA Group, Starburst Ventures, Cameron Winklevoss, Tyler Winklevoss, Danu Venture Group, Flintlock Capital, Gaingels, Rosecliff Venture Partners, Venture Science | ||||
 | ProbablyMonsters | Consumer & Lifestyle Gaming | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $260M | Series B | 8/6/2026 | $10M | $417.81M | $15.00 | Undisclosed Investors | ||||
 | Productiv | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $238.75M | Series D | 5/7/2024 | $5M | $96.54M | $0.70 | Undisclosed Investors | ||||
 | Prosetta Biosciences | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $63.64M | Series D | 12/31/2015 | $31.1M | $378.68M | $4.50 | Takeda Ventures, Alger | ||||
 | Pymetrics | Enterprise Software Human Resources | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $74.89M | Series B | 9/27/2018 | $58.05M | $199.87M | $6.45 | General Atlantic, Salesforce Ventures, Workday Ventures, Khosla Ventures, Jazz Venture Partners | ||||
 | Rainforest | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $58.37M | Series B | 9/8/2025 | $29.87M | $297.06M | $15.14 | Matrix Partners, Infinity Ventures, Accel, Tech Square Ventures | ||||
 | Rapport Therapeutics | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $250.18M | Series B | 8/7/2023 | $150M | $409.19M | $1.68 | Cormorant Asset Management, Fidelity Management & Research Company, Goldman Sachs Asset Management, Logos Capital, Perceptive Advisors, Sofinnova Investments, Surveyor Capital, Third Rock Ventures, ARCH Venture Partners, Johnson & Johnson Innovation | ||||
 | Ratio Therapeutics | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $151.27M | Series C | 7/31/2026 | $70M | $398.34M | $43.69 | Duquesne Family Office, Bristol Myers Squibb, Catalio Capital Management, Eli Lilly and Company, Wasatch Group | ||||
 | Recludix Pharma | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $123.5M | Series B | 1/12/2026 | $21.5M | $327.7M | $2.31 | Access Biotechnology, Alexandria Venture Investments, NEA, Westlake Village BioPartners, Eli Lilly | ||||
 | Reprise | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $63.96M | Series B | 11/9/2021 | $45M | $446.6M | $1.72 | ICONIQ Growth, Bain Capital Ventures, Accomplice VC, Glasswing Ventures | ||||
 | Retrace | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $18M | Series A | 5/12/2020 | $18M | $69.84M | $52.00 | Intel Capital, Stone Point Capital, SBVA | ||||
 | RiskIQ | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $88M | Series D | 6/4/2020 | $20M | $288.61M | $10.26 | National Grid Partners, Summit Partners, Battery Ventures, Georgian Partners, MassMutual Ventures | ||||
 | ROME Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $199M | Series B | 9/24/2021 | $149M | $321.94M | $1.49 | Johnson & Johnson Innovation, Bristol Myers Squibb, Eurofarma Ventures, Luma Group, Mirae Asset Capital, Raycap, Sigmas Group, ARCH Ventures, GV, Section 32, Sanofi Ventures, Andreessen Horowitz, Mass General Brigham Ventures, Casdin Capital, Alexandria Venture Investments | ||||
 | Sandstone | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $41.3M | Series A-1 | 6/9/2026 | $30.41M | $240.07M | $11.56 | Lightspeed Venture Partners, Sequoia Capital, Kearny Jackson, SV Angel, Webb Investment Network, Mantis VC, Antiportfolio Ventures, Daybreak Ventures, Operator Partners, Killer Whale Strategies, Litquidity Capital, Zach Abramowitz, Freddy Kerrest, Scott McNealy, Raji Arasu | ||||
 | Sapience Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $63.88M | Series B | 5/31/2022 | $28.25M | $289.73M | $3.60 | NexPoint, Bristol Myers Squibb, Eshelman Ventures, Kingdon Capital | ||||
 | Sapiom | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $47.94M | Series A-1 | 8/5/2026 | $32.62M | $284.15M | $15.16 | Dragonfly, Accel, Gradient, Coinbase Ventures, Operator Collective, Formus Capital, VanEck Ventures, Okta Ventures, Menlo Ventures, Anthropic, Array Ventures | ||||
 | Septerna | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $225M | Series B | 7/11/2023 | $150M | $313.42M | $1.23 | RA Capital Management, Third Rock Ventures, Samsara BioCapital, Invus, Catalio Capital Management, BVF Partners, Casdin Capital, Logos Capital, Deep Track Capital, Goldman Sachs Asset Management, Vertex Ventures HC, Mirae Asset Financial Group, Direhaus Capital Management, Woodline Partners LP, Soleus Capital | ||||
 | Singularity | Industrial Aerospace & Defense | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $110.59M | Series A-1 | 7/14/2026 | $74.72M | $400M | $11.53 | Khosla Ventures, Felicis, AE Ventures, NEA, Long Journey, Harpoon, Menlo Ventures, Y Combinator, Decisive Point, New Vista Capital, Sunflower Capital, Soma Capital | ||||
 | Solidus Labs | Fintech Blockchain | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $69.16M | Series B | 5/12/2022 | $30M | $288.82M | $13.09 | Liberty City Ventures, Evolution Equity Partners, Declaration Partners, Hanaco Ventures, Avon Ventures, Fidelity, Plural Ventures | ||||
 | Sooth Labs | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $50M | Series Seed-1 | 4/22/2026 | $49.55M | $335M | $27.76 | Felicis, Yann LeCun, Jeff Dean, Ardent Venture Partners | ||||
 | StreamSets | Enterprise Software Data Management / Storage | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $75.92M | Series C-1 | 4/22/2020 | $8.75M | $196.78M | $2.70 | Dcode Capital, Battery Ventures, New Enterprise Associates, Accel Partners | ||||
 | SynDevRx | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $52.6M | Series C | 9/30/2024 | $29.35M | $270.23M | $7.23 | Undisclosed Investors | ||||